已知易感位点中的罕见变异及其对肺癌风险的贡献
该研究对121个全基因组关联研究(GWAS)识别位点中的基因进行聚焦外显子测序,发现48个罕见有害变异,并在独立验证中确认12个候选变异,其中BRCA2 K3326X(OR=2.36,95%CI:1.38-3.99)和LTB p.Leu87Phe(OR=7.52,95%CI:1.01-16.56)等与肺癌易感性相关,提示胚系罕见编码变异在肺癌风险中的重要性。
要点
- BRCA2 K3326X与肺癌风险增加相关(OR=2.36,95%CI:1.38-3.99)。
- LTB p.Leu87Phe与肺癌风险强烈相关(OR=7.52,95%CI:1.01-16.56)。
- ZNF93、DAAM2、BRD9和LTB基因负荷测试与肺癌易感性显著关联。
核心结论
- 研究扩展了肺癌相关基因位点目录,强调胚系罕见编码变异在肺癌易感性中的重要作用。
研究设计与样本
- 对260例肺癌患者和318例对照的胚系DNA进行外显子测序,聚焦121个GWAS识别位点中的基因。
- 在1773例患者和1123例对照的两个独立验证研究中验证候选变异。
主要发现
- 发现48个罕见有害变异,并在验证平台上覆盖的43个候选变异中验证了12个。
- 验证的顶级候选包括BRCA2 K3326X(OR=2.36,95%CI:1.38-3.99)、LTB p.Leu87Phe(OR=7.52,95%CI:1.01-16.56)、P3H2 p.Gln185His(OR=5.39,95%CI:0.75-15.43)和DAAM2 p.Asp762Gly(OR=0.25,95%CI:0.10-0.79)。
- 负荷测试显示ZNF93、DAAM2、BRD9和LTB基因与肺癌易感性强烈关联。
临床怎么用
- BRCA2 K3326X等罕见变异可作为肺癌风险评价的候选标记,但需进一步临床验证。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND: Genome-wide association studies are widely used to map genomic regions contributing to lung cancer (LC) susceptibility, but they typically do not identify the precise disease-causing genes/variants. To unveil the inherited genetic variants that cause LC, we performed focused exome-sequencing analyses on genes located in 121 genome-wide association study-identified loci previously implicated in the risk of LC, chronic obstructive pulmonary disease, pulmonary function level, and smoking behavior. METHODS: Germline DNA from 260 case patients with LC and 318 controls were sequenced by utilizing VCRome 2.1 exome capture. Filtering was based on enrichment of rare and potential deleterious variants in cases (risk alleles) or controls (protective alleles). Allelic association analyses of single-variant and gene-based burden tests of multiple variants were performed. Promising candidates were tested in two independent validation studies with a total of 1773 case patients and 1123 controls. RESULTS: We identified 48 rare variants with deleterious effects in the discovery analysis and validated 12 of the 43 candidates that were covered in the validation platforms. The top validated candidates included one well-established truncating variant, namely, BRCA2, DNA repair associated gene (BRCA2) K3326X (OR = 2.36, 95% confidence interval [CI]: 1.38-3.99), and three newly identified variations, namely, lymphotoxin beta gene (LTB) p.Leu87Phe (OR = 7.52, 95% CI: 1.01-16.56), prolyl 3-hydroxylase 2 gene (P3H2) p.Gln185His (OR = 5.39, 95% CI: 0.75-15.43), and dishevelled associated activator of morphogenesis 2 gene (DAAM2) p.Asp762Gly (OR = 0.25, 95% CI: 0.10-0.79). Burden tests revealed strong associations between zinc finger protein 93 gene (ZNF93), DAAM2, bromodomain containing 9 gene (BRD9), and the gene LTB and LC susceptibility. CONCLUSION: Our results extend the catalogue of regions associated with LC and highlight the importance of germline rare coding variants in LC susceptibility.
引用
- Liu Y, Lusk CM, Cho MH, et al. Rare Variants in Known Susceptibility Loci and Their Contribution to Risk of Lung Cancer. J Thorac Oncol. 2018. PMID: 29981437. doi:10.1016/j.jtho.2018.06.016
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。